Shanghai ZJ Bio-Tech Co., Ltd (SHA:688317)
China · Delayed Price · Currency is CNY 16.93
-0.01 (-0.06%)
Sep 4, 2026, 3:00 PM CST
Shanghai ZJ Bio-Tech Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,959 | 3,581 | 3,085 | 4,031 | 6,418 | 10,055 | |
Market Cap Growth | -34.98% | 16.06% | -23.48% | -37.19% | -36.17% | - |
Enterprise Value | 457 | 966 | 346 | 1,279 | 3,413 | 7,341 |
Last Close Price | 16.93 | 20.17 | 16.25 | 20.84 | 31.66 | 47.40 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | 8.44 | 13.26 |
PS Ratio | 24.96 | 28.69 | 17.27 | 14.70 | 2.76 | 4.98 |
PB Ratio | 0.91 | 1.07 | 0.85 | 1.05 | 1.53 | 2.63 |
P/TBV Ratio | 0.92 | 1.07 | 0.85 | 1.06 | 1.53 | 2.64 |
P/FCF Ratio | 97.31 | 55.21 | 53.09 | - | 12.57 | 69.88 |
P/OCF Ratio | 56.22 | 53.56 | 39.76 | - | 10.97 | 15.66 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.86 | 7.74 | 1.94 | 4.66 | 1.47 | 3.64 |
EV/EBITDA Ratio | - | - | - | - | 4.32 | 8.21 |
EV/EBIT Ratio | - | - | - | - | 4.65 | 8.44 |
EV/FCF Ratio | 15.04 | 14.90 | 5.95 | - | 6.69 | 51.03 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.09 | 0.09 | 0.00 | 0.00 | 0.00 | - |
Debt / EBITDA Ratio | - | - | - | - | 0.01 | - |
Debt / FCF Ratio | 9.63 | 4.61 | 0.09 | - | 0.02 | - |
Net Debt / Equity Ratio | -0.77 | -0.78 | -0.76 | -0.72 | -0.75 | -0.77 |
Net Debt / EBITDA Ratio | 174.77 | 93.73 | 14.39 | 13.98 | -3.97 | -3.28 |
Net Debt / FCF Ratio | -82.27 | -40.11 | -47.82 | 16.94 | -6.15 | -20.41 |
Asset Turnover | 0.03 | 0.03 | 0.05 | 0.06 | 0.52 | 0.66 |
Inventory Turnover | 0.67 | 0.66 | 1.39 | 0.75 | 2.81 | 3.54 |
Quick Ratio | 24.94 | 23.17 | 19.60 | 12.25 | 6.46 | 7.90 |
Current Ratio | 25.38 | 23.59 | 20.11 | 13.38 | 7.46 | 8.69 |
Return on Equity (ROE) | -1.94% | -0.98% | -3.42% | -3.41% | 18.94% | 28.68% |
Return on Assets (ROA) | -1.31% | -1.51% | -4.12% | -3.70% | 10.19% | 17.72% |
Return on Invested Capital (ROIC) | -10.23% | -11.36% | -27.00% | -24.58% | 63.38% | 128.08% |
Return on Capital Employed (ROCE) | -2.20% | -2.50% | -7.10% | -6.80% | 17.40% | 22.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -2.20% | -0.96% | -4.13% | -3.40% | 11.85% | 7.54% |
FCF Yield | 1.03% | 1.81% | 1.88% | -4.04% | 7.95% | 1.43% |
Dividend Yield | - | - | 0.68% | - | 3.79% | 2.88% |
Payout Ratio | - | - | - | - | 34.94% | 41.07% |
Buyback Yield / Dilution | 13.09% | 5.11% | 1.30% | 0.36% | -1.51% | -30.46% |
Total Shareholder Return | 13.09% | 5.11% | 1.98% | 0.36% | 2.28% | -27.58% |